Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-054612
Date:2021-09-02
Issuer: BIOCEPT INC (BIOC)
Original Submission Date:

Reporting Person:

NALL MICHAEL W.
C/O BIOCEPT, INC.
9955 MESA RIM ROAD SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 3.76 2021-09-02 deemed execution date A 100,000 (a) 2031-09-01 common stock 100,000 $3.76 100,000 direct
PERFORMANCE-BASED EMPLOYEE STOCK OPTION (RIGHT TO BUY) 3.76 2021-09-02 deemed execution date A 80,000 (a) 2031-09-01 common stock 80,000 $3.76 80,000 direct
Footnotes
IDfootnote
f1 1/36th of the shares subject to the option shall vest monthly following the vesting commencement date of 9/2/21 until fully vested on 9/2/2024.
f2 1/36th of the shares subject to the option shall vest monthly, commencing upon the issuer's achievement of a specified corporate milestone.
WhaleWisdom Logo

Elevate your investments